Your browser doesn't support javascript.
loading
Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.
Zheng, Xubin; Jongedijk, Erwin M; Hu, Yi; Kuhlin, Johanna; Zheng, Rongrong; Niward, Katarina; Paues, Jakob; Xu, Biao; Davies Forsman, Lina; Schön, Thomas; Bruchfeld, Judith; Alffenaar, Jan-Willem C.
Afiliação
  • Zheng X; Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, China.
  • Jongedijk EM; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Hu Y; Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, China. Electronic address: yhu@fudan.edu.cn.
  • Kuhlin J; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Zheng R; Department of Tuberculosis and AIDS Prevention, Xiamen Centre for Disease Control and Prevention, Xiamen, China.
  • Niward K; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Infectious Diseases, Linköping University, Linkoping, Sweden.
  • Paues J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Infectious Diseases, Linköping University, Linkoping, Sweden.
  • Xu B; Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, China.
  • Davies Forsman L; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Schön T; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Clinical Microbiology and Infectious Diseases, Kalmar County Hospital, Kalmar, Sweden.
  • Bruchfeld J; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Alffenaar JC; University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia; Westmead Hospital, Sydney, Australia; Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia.
J Chromatogr B Analyt Technol Biomed Life Sci ; 1158: 122397, 2020 Nov 20.
Article em En | MEDLINE | ID: mdl-33091676
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protionamida / Pirazinamida / Cromatografia Líquida / Fluoroquinolonas / Etambutol Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Chromatogr B Analyt Technol Biomed Life Sci Assunto da revista: ENGENHARIA BIOMEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protionamida / Pirazinamida / Cromatografia Líquida / Fluoroquinolonas / Etambutol Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Chromatogr B Analyt Technol Biomed Life Sci Assunto da revista: ENGENHARIA BIOMEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China